Evidence map›Paper›PMID 15925705›Full record

ReviewTrends in pharmacological sciences2005

Nitrosative stress and pharmacological modulation of heart failure.

Pal Pacher, Richard Schulz, Lucas Liaudet, Csaba Szabó

Registry-linked trialOpen access · greenAbstract readReview
In one paragraph

Review in Trends in pharmacological sciences, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03012022 (Nitrative Stress in Heart Failure), which is not on this map. Cited by 87 papers.

0numbers the graph read from it
0cells of the map it votes in
87citing papers in PubMed
13.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03012022 active not recruitingnot on this mapstarted 2010, after this paper: background citation

Nitrative Stress in Heart Failure: The Cleveland Heart and Metabolic Prevention Study (CHAMPS)

TypeobservationalSponsorThe Cleveland ClinicRan2010 to 2027Enrolled1,208ConditionsHeart Failure Risk Factors in Healthy Individuals
3 · Its place in the literature

Who cites it

87 citing papers in PubMed, 234 citations in OpenAlex.

  1. Trial
  2. Review
  3. The Link between Alcohol Consumption and Kidney Injury.The American journal of pathology · 2026
    Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Antioxidant and Anticholinesterase Properties of the Aqueous Extract ofEvidence-based complementary and alternative medicine : eCAM · 2022
    Article
  10. Article
  11. Review
  12. Parenteral Nutrition and Cardiotoxicity.Cardiovascular toxicology · 2021
    Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article

27 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 3 countries.

Pal PacherLaboratory of Physiological Studies, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, 5625 Fishers Lane MSC 9413, Room 2S24, Bethesda, MD 20892-9413, USA. ppacher@lycos.com
Richard Schulz
Lucas Liaudet
Csaba Szabó
Inotek Pharmaceuticals (United States) · USNational Institutes of Health · USUniversity of Alberta · CA

Funding

Mechanism of oxidative/nitrosative stress and inflammation-induced tissue injuryZIAAA000375 · NIAAA · NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM · PI PACHER, PAL · 2009 to 2025
$27.8M
Mechanism of oxidative/nitrosative stress and inflammation-induced tissue injuryZ01AA000375 · NIAAA · NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM · PI PACHER, PAL · 2006 to 2008
$1.3M
Intramural NIH HHS Z01 AA000375
6 · The paper itself

Abstract

Dysregulation of nitric oxide (NO) and increased oxidative and nitrosative stress are implicated in the pathogenesis of heart failure. Peroxynitrite is a reactive oxidant that is produced from the reaction of nitric oxide with superoxide anion and impairs cardiovascular function through multiple mechanisms, including activation of matrix metalloproteinases (MMPs) and nuclear enzyme poly(ADP-ribose) polymerase (PARP). Recent studies suggest that the neutralization of peroxynitrite or pharmacological inhibition of MMPs and PARP are promising new approaches in the experimental therapy of various forms of myocardial injury. In this article, the role of nitrosative stress and downstream mechanisms, including activation of MMPs and PARP, in various forms of heart failure are discussed and novel emerging therapeutic strategies offered by neutralization of peroxynitrite and inhibition of MMPs and PARP in these pathophysiological conditions are reviewed.

Indexed as

Oxidative StressEnzyme ActivationEnzyme InhibitorsHeart FailureHumansMatrix Metalloproteinase 2Matrix Metalloproteinase 9Nitric OxideNitric Oxide SynthasePeroxynitrous AcidPoly(ADP-ribose) Polymerase InhibitorsPoly(ADP-ribose) PolymerasesEnzyme InhibitorsMatrix Metalloproteinase 2Matrix Metalloproteinase 9Nitric OxideNitric Oxide SynthasePeroxynitrous AcidPoly(ADP-ribose) Polymerase InhibitorsPoly(ADP-ribose) Polymerases

Identifiers

PMID15925705
PMCPMC2228264
OpenAlexW2041956415

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.